OncoRev Revenue
Investment Management • 
Stamford, Connecticut, United States • 1-10 Employees
$
OncoRev revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Investment Management industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Key Contact at OncoRev
Henrik Brun
Co-Founder
Company overview
| Headquarters | 263 Tresser Blvd, Stamford, Connecticut 06901, US |
| NAICS | 5231 |
| Keywords | Biotech, Data Science, Cancer, Early Detection, Early Prevention |
| Founded | 2022 |
| Employees | 1-10 |
About OncoRev
OncoRev is an alternative asset manager dedicated exclusively to oncology. Together with our investors we seek to change the cancer survival curve by investing in innovation and giving to our charitable partner the Cancer Research Insitute.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Founder/Owner
Employees by Department
OncoRev has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
OncoRev has never raised funding before.
New Zealand
Hong Kong
Spain
United Kingdom
Frequently asked questions
OncoRev is located in Stamford, Connecticut, US.
OncoRev generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.
OncoRev has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
OncoRev was founded in 2022, making it 4 years old. The company has established itself as a significant player in its industry over this time.
OncoRev has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
